PhysioSonics, the Bellevue, WA-based developer of ultrasound technology for monitoring blood flow in the brain for patients with stroke or traumatic brain injury, has raised $2 million in equity out of a $4 million offering, according to a regulatory filing. The company, a University of Washington spinout, is led by CEO Brad Harlow. It raised $4 million last June from Johnson & Johnson Development Corporation. It lists Harlow, Robert Frederickson, Lauren Pflugrath, and Scott Moonly as directors.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
